| Trial ID: | L5804 |
| Source ID: | NCT00660075
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00660075/results
|
| Conditions: |
Diabetes Mellitus|Postprandial Lipemia
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Measurement of the Area Under the Curve of Plasma Triglycerides (TG) Levels During Postprandial Period (Time 0,2,4,6,8 Hours), At the end of the two 6-week interventions |
|
| Sponsor/Collaborators: |
Sponsor: Laval University | Collaborators: Merck Sharp & Dohme LLC
|
| Gender: |
MALE
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-02
|
| Completion Date: |
2009-04
|
| Results First Posted: |
2012-12-11
|
| Last Update Posted: |
2012-12-11
|
| Locations: |
Laval University Medical Center, Quebec City, Quebec, G1V 4G2, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT00660075
|
